isoproterenol and salmeterol xinafoate

isoproterenol has been researched along with salmeterol xinafoate in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's23 (50.00)18.2507
2000's9 (19.57)29.6817
2010's11 (23.91)24.3611
2020's3 (6.52)2.80

Authors

AuthorsStudies
Barrett, VJ; Bevan, NJ; Biggadike, K; Butchers, PR; Coe, DM; Conroy, R; Edney, DD; Field, RN; Ford, AJ; Guntrip, SB; Looker, BE; McLay, IM; Monteith, MJ; Morrison, VS; Mutch, PJ; Procopiou, PA; Richards, SA; Sasse, R; Smith, CE1
Barrett, VJ; Bevan, NJ; Biggadike, K; Box, PC; Butchers, PR; Coe, DM; Conroy, R; Emmons, A; Ford, AJ; Holmes, DS; Horsley, H; Kerr, F; Li-Kwai-Cheung, AM; Looker, BE; Mann, IS; McLay, IM; Morrison, VS; Mutch, PJ; Procopiou, PA; Smith, CE; Tomlin, P1
Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Fisher, A; Flaherty, A; Hill, S; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; St-Gallay, S; Stocks, MJ; Young, A1
Barrett, VJ; Bevan, NJ; Butchers, PR; Conroy, R; Emmons, A; Ford, AJ; Jeulin, S; Looker, BE; Lunniss, GE; Morrison, VS; Mutch, PJ; Perciaccante, R; Procopiou, PA; Ruston, M; Smith, CE; Somers, G1
Barrett, VJ; Ford, AJ; Looker, BE; Lunniss, GE; Needham, D; Procopiou, PA; Smith, CE; Somers, G1
Gmeiner, P; Hübner, H; Stanek, M; Weichert, D1
Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C1
Cheng, M; Jing, X; Lin, B; Pan, L; Xing, G; Yi, C; Yiu-Ho Woo, A; Zhang, Y; Zhi, Z; Zou, J1
Bousquet, J; Michel, FB1
Fujiwara, H; Kudo, M; Maeda, M; Nishimura, M; Okiyama, M; Simizu, M; Toshimitsu, Y; Yamada, M1
Ball, DI; Brittain, RT; Coleman, RA; Denyer, LH; Jack, D; Johnson, M; Lunts, LH; Nials, AT; Sheldrick, KE; Skidmore, IF1
Dougall, IG; Harper, D; Jackson, DM; Leff, P1
Johnson, M1
Johansson, I; Ryberg, M1
Baker, AJ; Fuller, RW; Johnson, M; Palmer, J1
Allen, MJ; Coleman, RA1
Hill, SJ; McCrea, KE2
Cole, PJ; Cundell, DR; Johnson, M; Kanthakumar, K; Taylor, GW; Wills, PJ; Wilson, R1
Coleman, RA; Johnson, M; Nials, AT; Sumner, MJ1
Berry, JL; Chiu, P; Cook, SJ; Downing, SJ; Foster, RW; Small, RC1
Douglas, JS; Grandordy, B; Roux, FJ1
Brons, FM; Mohede, IC; Nijkamp, FP; Van Ark, I; Van Oosterhout, AJ1
Gonsiorek, W; Kavaler, JP; Maayani, S; Schachter, EN; Sugár, IP; Wachsman, DE1
Barnes, PJ; Mak, JC; Nishikawa, M1
Bertin, B; Jockers, R; Marullo, S; Strosberg, AD1
Befus, AD; Bissonnette, EY1
Chong, LK; Cooper, E; Peachell, PT; Vardey, CJ1
Bevan, NJ; Hill, SJ; Latif, ML; McDonnell, J; Rees, ES1
Lemoine, H; Teschemacher, A1
Bao, Y; Lemoine, H1
Green, SA; Liggett, SB; Rathz, DA; Schuster, AJ1
Chess-Williams, R; Chong, LK; Peachell, PT; Scola, AM; Suvarna, SK1
Carter, AA; Hill, SJ1
Janssen, LJ; Liu, C; Zuo, J1
Elling, C; Elster, L; Heding, A1
Advenier, C; Fairhurst, RA; Molimard, M; Naline, E; Trifilieff, A1
Kassel, KM; Panettieri, RA; Toews, ML; Wyatt, TA1
Virchow, C1
Deshpande, DA; Miles, MC; Misior, AM; Panettieri, RA; Pascual, RM; Penn, RB; Riemer, EC; Saxena, H; Yan, H1
Ishii, K; Nakahara, T; Saito, M; Sakamoto, K; Yonoki, Y; Yoshihara, T1
Baameur, F; Clark, RB; Gimenez, LE; Vayttaden, SJ1
Johnson, JR; Krogan, NJ; Newton, BW; Riordan, DP; Sundaram, AB; Trester-Zedlitz, M; Tsvetanova, NG; von Zastrow, M1
Bouvier, M; Gmeiner, P; Hübner, H; Kaindl, JM; Picard, LP; Schmidt, MF; Stanek, M; Weikert, D1
Ali, A; Emran, TB; Imran, M; Ismail, ISB; Latif, Z; Muhammad, N; Saeed, L; Safi, SZ; Shah, H; Subramaniyan, V1
Behuliak, M; Valovič, P; Vaněčková, I; Zicha, J1

Reviews

2 review(s) available for isoproterenol and salmeterol xinafoate

ArticleYear
The pharmacology of salmeterol.
    Lung, 1990, Volume: 168 Suppl

    Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Animals; Clenbuterol; Delayed-Action Preparations; Guinea Pigs; Humans; Isoproterenol; Muscle, Smooth; Receptors, Adrenergic, beta; Salmeterol Xinafoate

1990
[Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134 Suppl 10

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethanolamines; Forced Expiratory Volume; Formoterol Fumarate; Humans; Isoproterenol; Patient Compliance; Randomized Controlled Trials as Topic; Risk; Salmeterol Xinafoate; Survival Rate; Tachyphylaxis

2009

Other Studies

44 other study(ies) available for isoproterenol and salmeterol xinafoate

ArticleYear
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
    Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8

    Topics: 2-Hydroxyphenethylamine; Administration, Oral; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Biological Availability; Bronchi; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dogs; Guinea Pigs; Humans; In Vitro Techniques; Microsomes; Models, Molecular; Muscle Contraction; Muscle, Smooth; Rats; Salmeterol Xinafoate; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Trachea

2009
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
    Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Benzyl Alcohol; Benzyl Alcohols; Chlorobenzenes; CHO Cells; Cricetinae; Cricetulus; Humans; Models, Molecular; Protein Conformation; Rats; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2010
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonists.
    Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13

    Topics: Adrenergic beta-2 Receptor Agonists; Animals; Bronchi; Cell Line; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2011
The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.
    Bioorganic & medicinal chemistry, 2011, Jul-15, Volume: 19, Issue:14

    Topics: Adrenergic beta-2 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Female; Guinea Pigs; Hepatocytes; Humans; Hydantoins; Male; Microsomes, Liver; Molecular Structure; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Stereoisomerism; Trachea; Uracil

2011
The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.
    Bioorganic & medicinal chemistry, 2011, Oct-15, Volume: 19, Issue:20

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthenia; Bronchodilator Agents; CHO Cells; Cricetinae; Cricetulus; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Male; Rats; Salmeterol Xinafoate; Stereoisomerism; Urea

2011
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.
    Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12

    Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2

2016
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
    Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12

    Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2016
8-Hydroxyquinolin-2(1H)-one analogues as potential β
    European journal of medicinal chemistry, 2021, Nov-15, Volume: 224

    Topics: Animals; Dose-Response Relationship, Drug; Drug Design; Guinea Pigs; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Quinolines; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2021
[Pharmacological properties of salmeterol].
    Revue des maladies respiratoires, 1992, Volume: 9 Suppl 1

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchi; Guinea Pigs; Humans; In Vitro Techniques; Isoproterenol; Mast Cells; Muscle, Smooth; Receptors, Adrenergic, beta; Salmeterol Xinafoate; Time Factors

1992
[Pharmacological action of SN-408, a novel long-acting selective beta 2-adrenoceptor agonist].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1991, Volume: 98, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchodilator Agents; Capillary Permeability; Dose-Response Relationship, Drug; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Mice; Procaterol; Salmeterol Xinafoate

1991
Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    British journal of pharmacology, 1991, Volume: 104, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchodilator Agents; Dinoprost; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth; Propranolol; Rats; Salmeterol Xinafoate; Stomach; Trachea

1991
Estimation of the efficacy and affinity of the beta 2-adrenoceptor agonist salmeterol in guinea-pig trachea.
    British journal of pharmacology, 1991, Volume: 104, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Drug Interactions; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Models, Biological; Salmeterol Xinafoate; Trachea

1991
The effects of long-term treatment with salmeterol and salbutamol on the flow rate and composition of whole saliva in the rat.
    Archives of oral biology, 1995, Volume: 40, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Amylases; Analysis of Variance; Animals; Calcium; Electrolytes; Hexosamines; Isoproterenol; Male; N-Acetylneuraminic Acid; Organ Size; Parotid Gland; Pilocarpine; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Salivary Proteins and Peptides; Salivation; Salmeterol Xinafoate; Secretory Rate; Sialic Acids; Statistics, Nonparametric; Stimulation, Chemical; Submandibular Gland

1995
Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Calcimycin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Isoproterenol; Macrophages, Alveolar; Monocytes; Propranolol; Salmeterol Xinafoate; Sodium Fluoride; Thromboxane B2; Zymosan

1994
Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
    European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albumins; Albuterol; Analysis of Variance; Animals; Capillary Permeability; Catechols; Cattle; Cells, Cultured; Dioxoles; Dose-Response Relationship, Drug; Endothelium, Vascular; Evans Blue; Hydrogen Peroxide; Isoproterenol; Lipopolysaccharides; Nitroprusside; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Thrombin; Thromboxane A2; Vasoconstrictor Agents

1995
Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
    British journal of pharmacology, 1993, Volume: 110, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Central Nervous System Neoplasms; Cyclic AMP; Isoproterenol; Neuroblastoma; Neurons; Rats; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Tumor Cells, Cultured

1993
Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.
    British journal of pharmacology, 1994, Volume: 112, Issue:2

    Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Bronchodilator Agents; Cells, Cultured; Cyclic AMP; Epithelial Cells; Epithelium; Humans; Isoproterenol; Mucociliary Clearance; Nasal Mucosa; Pseudomonas aeruginosa; Pyocyanine; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

1994
Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
    British journal of pharmacology, 1993, Volume: 108, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Isoproterenol; Lung; Male; Muscle Relaxation; Muscle, Smooth; Perfusion; Radioligand Assay; Rats; Salmeterol Xinafoate; Sotalol; Time Factors

1993
Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
    British journal of pharmacology, 1993, Volume: 109, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzopyrans; Cell Membrane; Cromakalim; Electrophysiology; Female; Guinea Pigs; Heart; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth; Myocardium; Norepinephrine; Potassium Channels; Procaterol; Propanolamines; Pyrroles; Receptors, Adrenergic, beta; Rubidium Radioisotopes; Salmeterol Xinafoate; Trachea

1993
Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor.
    Molecular pharmacology, 1996, Volume: 49, Issue:5

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Ethanolamines; Formoterol Fumarate; Glioma; Isoproterenol; Rats; Salmeterol Xinafoate; Time Factors; Tumor Cells, Cultured

1996
Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:5

    Topics: Adrenergic beta-Agonists; Albuterol; Aminophylline; Animals; Binding, Competitive; Bronchoconstriction; Bronchodilator Agents; Ethanolamines; Female; Fenoterol; Formoterol Fumarate; Guanine Nucleotides; Guinea Pigs; Heart; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lung; Pindolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Trachea

1996
Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells.
    International journal of immunopharmacology, 1996, Volume: 18, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Cell Division; Dose-Response Relationship, Drug; Humans; Interferon-gamma; Interleukin-4; Isoproterenol; Leukocytes, Mononuclear; Phytohemagglutinins; Salmeterol Xinafoate

1996
Kinetic studies of desensitization and resensitization of the relaxation response to beta-2 adrenoceptor agonists in isolated guinea pig trachea.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Carbachol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Potassium Chloride; Propranolol; Salmeterol Xinafoate; Trachea

1997
Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung.
    European journal of pharmacology, 1996, Dec-27, Volume: 318, Issue:1

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Binding Sites; Binding, Competitive; Blotting, Northern; Down-Regulation; Ethanolamines; Formoterol Fumarate; Humans; In Vitro Techniques; Isoproterenol; Lung; Male; Receptors, Adrenergic, beta-2; RNA, Messenger; Salmeterol Xinafoate

1996
Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines.
    Receptors & channels, 1997, Volume: 5, Issue:1

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Albuterol; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Colforsin; Cyclic AMP; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, Gs; Iodocyanopindolol; Isoproterenol; Mice; Pindolol; ras Proteins; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Salmeterol Xinafoate; Signal Transduction; Transfection; Tumor Cells, Cultured

1997
Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
    The Journal of allergy and clinical immunology, 1997, Volume: 100, Issue:6 Pt 1

    Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Cell Separation; Child, Preschool; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Histamine Release; Humans; Immunoglobulin E; Isoproterenol; Mast Cells; Salmeterol Xinafoate; Skin; Tumor Necrosis Factor-alpha

1997
Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    British journal of pharmacology, 1998, Volume: 123, Issue:5

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Histamine Release; Humans; In Vitro Techniques; Isoproterenol; Lung; Mast Cells; Salmeterol Xinafoate

1998
Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
    British journal of pharmacology, 1998, Volume: 125, Issue:4

    Topics: Adrenergic beta-Agonists; Albuterol; Alkaline Phosphatase; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Iodocyanopindolol; Isoproterenol; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Transcription, Genetic; Transfection

1998
Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Binding, Competitive; Bronchodilator Agents; Cattle; Cell Membrane; Ethanolamines; Formoterol Fumarate; In Vitro Techniques; Isoproterenol; Lung; Membranes; Muscle, Smooth; Pindolol; Radioligand Assay; Rats; Receptors, Drug; Salmeterol Xinafoate; Sympathomimetics; Trachea

1999
[Inquiry into the mechanism of long-acting bronchodilators].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1998, Volume: 20, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Binding, Competitive; Bronchi; Bronchodilator Agents; Cattle; Cell Membrane; Cyclic AMP; Delayed-Action Preparations; Ethanolamines; Fenoterol; Formoterol Fumarate; Isoproterenol; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

1998
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
    European journal of pharmacology, 2001, Jun-15, Volume: 421, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Genotype; Humans; Iodine Radioisotopes; Isoproterenol; Metaproterenol; Pindolol; Polymorphism, Genetic; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline

2001
Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    British journal of pharmacology, 2004, Volume: 141, Issue:1

    Topics: Albuterol; Cell Membrane; Colforsin; Cyclic AMP; Desensitization, Immunologic; Dose-Response Relationship, Drug; Ethanolamines; Female; Formoterol Fumarate; Histamine Release; Humans; Immunoglobulin E; Isoproterenol; Lung; Male; Mast Cells; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Time Factors

2004
Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; beta-Galactosidase; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Genetic Complementation Test; Humans; Isoproterenol; Mutation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Salmeterol Xinafoate; Transfection

2005
Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli.
    The European respiratory journal, 2006, Volume: 28, Issue:4

    Topics: Albuterol; Animals; Bronchodilator Agents; Carbachol; Cattle; Cholinergic Agonists; Dose-Response Relationship, Drug; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isoproterenol; Muscle Tonus; Muscle, Smooth; Nitric Oxide Donors; Penicillamine; Protein Serine-Threonine Kinases; rho-Associated Kinases; rhoA GTP-Binding Protein; Salmeterol Xinafoate; Signal Transduction; Trachea

2006
Bioluminescence resonance energy transfer as a screening assay: Focus on partial and inverse agonism.
    Journal of biomolecular screening, 2007, Volume: 12, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Chlorocebus aethiops; COS Cells; Cyclic AMP; Energy Transfer; Humans; Isoproterenol; Salmeterol Xinafoate; Spectrometry, Fluorescence

2007
Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
    The European respiratory journal, 2007, Volume: 29, Issue:3

    Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Bronchi; Bronchoconstriction; Dose-Response Relationship, Drug; Electric Stimulation; Ethanolamines; Female; Formoterol Fumarate; Humans; In Vitro Techniques; Indans; Isoproterenol; Male; Middle Aged; Muscle, Smooth; Quinolones; Salmeterol Xinafoate; Treatment Outcome

2007
Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement.
    American journal of physiology. Lung cellular and molecular physiology, 2008, Volume: 294, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Cell Culture Techniques; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Epidermal Growth Factor; Guanine Nucleotide Exchange Factors; Humans; Isoproterenol; Muscle, Smooth; Receptors, Adrenergic, beta-2; Respiratory Physiological Phenomena; Salmeterol Xinafoate

2008
Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adrenergic beta-2 Receptor Agonists; Albuterol; Bronchodilator Agents; Cell Proliferation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Activation; Epidermal Growth Factor; Green Fluorescent Proteins; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Phosphorylation; Salmeterol Xinafoate; Time Factors; Trachea; Transfection

2011
Agonist-induced receptor internalization in Chinese hamster ovary cells stably co-expressing β(1)- and β(2)-adrenergic receptors.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Isoproterenol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

2013
Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
    Molecular pharmacology, 2015, Volume: 87, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Albuterol; Animals; Arrestins; beta-Arrestins; Chlorocebus aethiops; COS Cells; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; G-Protein-Coupled Receptor Kinases; Humans; Isoproterenol; Myocytes, Smooth Muscle; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

2015
G Protein-Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands.
    Molecular pharmacology, 2017, Volume: 91, Issue:2

    Topics: Endocytosis; Endosomes; HEK293 Cells; Humans; Isoproterenol; Ligands; Mass Spectrometry; Models, Biological; Oligonucleotide Array Sequence Analysis; Phosphoproteins; Phosphorylation; Proteome; Proteomics; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Salmeterol Xinafoate; Signal Transduction; Transcription, Genetic

2017
Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.
    Journal of medicinal chemistry, 2019, 05-23, Volume: 62, Issue:10

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; beta-Arrestins; Carvedilol; Catechols; Drug Design; GTP-Binding Proteins; Humans; Hydrogen Bonding; Indicators and Reagents; Isoproterenol; Ligands; Mice; Models, Molecular; Molecular Dynamics Simulation; Salmeterol Xinafoate

2019
Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells.
    Molecular biology reports, 2022, Volume: 49, Issue:10

    Topics: Adrenergic beta-Agonists; Brain-Derived Neurotrophic Factor; Caspase 3; Caspase 8; Cyclic AMP Response Element-Binding Protein; Cytochromes c; Ependymoglial Cells; Glucose; Humans; Isoproterenol; Propranolol; Reactive Oxygen Species; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Xamoterol

2022
Impaired vascular β-adrenergic relaxation in spontaneously hypertensive rats: The differences between conduit and resistance arteries.
    European journal of pharmacology, 2023, Nov-05, Volume: 958

    Topics: Adrenergic Agents; Adrenergic beta-Agonists; Animals; Endothelium, Vascular; Hypertension; Isoproterenol; Mesenteric Arteries; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Salmeterol Xinafoate; Vascular Resistance

2023